|
ERH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.062470E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.597300E-03 |
| Normal-vs-Stage2 |
7.558800E-04 |
| Normal-vs-Stage3 |
1.244450E-03 |
| Normal-vs-Stage4 |
2.991800E-02 |
| Stage1-vs-Stage2 |
1.291630E-01 |
| Stage1-vs-Stage3 |
2.104200E-01 |
| Stage1-vs-Stage4 |
9.308000E-01 |
| Stage2-vs-Stage3 |
8.142600E-01 |
| Stage2-vs-Stage4 |
2.934200E-01 |
| Stage3-vs-Stage4 |
4.045200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.373800E-04 |
| Normal-vs-AfricanAmerican |
7.618300E-02 |
| Normal-vs-Asian |
8.454400E-01 |
| Caucasian-vs-AfricanAmerican |
2.990200E-01 |
| Caucasian-vs-Asian |
1.673190E-01 |
| AfricanAmerican-vs-Asian |
3.014200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.002410E-03 |
| Normal-vs-Female |
5.563000E-03 |
| Male-vs-Female |
2.586800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.923800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.983900E-03 |
| Normal-vs-Age(61-80Yrs) |
3.783600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.650000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.121420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.877600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.597750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.555400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.111400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.943000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.032600E-01 |
| Normal-vs-Grade 2 |
1.801540E-02 |
| Normal-vs-Grade 3 |
7.75610000000038E-05 |
| Normal-vs-Grade 4 |
1.767860E-02 |
| Grade 1-vs-Grade 2 |
2.310800E-01 |
| Grade 1-vs-Grade 3 |
8.737100E-03 |
| Grade 1-vs-Grade 4 |
1.148240E-01 |
| Grade 2-vs-Grade 3 |
6.564200E-03 |
| Grade 2-vs-Grade 4 |
3.991600E-01 |
| Grade 3-vs-Grade 4 |
4.317600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.335370E-03 |
| Normal-vs-ccB subtype |
2.161400E-03 |
| ccA subtype-vs-ccB subtype |
4.923400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.759000E-03 |
| Normal-vs-N1 |
3.019600E-03 |
| N0-vs-N1 |
2.186800E-01 |
|
|
